ECDC and Spanish Ministry of Health workshop:

Similar documents
ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC s role in the fight against HIV/AIDS in Europe

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Key issues for HIV testing and

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

HIV/AIDS, STI, hepatitis

New trends in harm reduction in Europe: progress made challenges ahead

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Behavioural indicators in men who have sex with men

HIV/AIDS Joint Action HA-REACT

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Overview of drug-induced deaths in Europe - What does the data tell us?

Monthly measles and rubella monitoring report

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

HIV, HBV and HCV testing policy experiences and lessons learned.

Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity

PrEP for HIV prevention. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech

Activities in 2010, Priorities for 2011

Fakoya et al. BMC Public Health (2015) 15:561 DOI /s

Drug-related infectious diseases

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Monitoraggio delle epatiti virali in Europa

TB/HIV in the WHO European Region Overview, Priorities & Response

A phylodynamic analysis of HIV-1 in Germany

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Lymphogranuloma venereum

Measles and rubella monitoring January 2015

Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018

HIV, Hepatitis and TB in Sweden Epidemiological data and prevention activities

Smokefree Policies in Europe: Are we there yet?

10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest.

Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

European monthly measles monitoring (EMMO)

HIV testing in Europe: From policy to effectiveness

Cross Border Genetic Testing for Rare Diseases

NO DISCLOSURES TO DECLARE

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland

HIV and Harm Reduction in Prisons

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

HIV transmission in the migrant population. D. Paraskevis

Annual Epidemiological Report

Government of Canada Federal AIDS Initiative Milestones

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011

Cascade of care among migrants in Belgium and in Europe. Dr Rémy Demeester Aids Reference Centre of Charleroi 24th of November 2017 BREACH Symposium

HIV in the United Kingdom

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland:

EUVAC.NET A surveillance network for vaccine-preventable diseases

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Underage drinking in Europe

European status report on alcohol and health Leadership, awareness and commitment

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Giardiasis (lambliasis)

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology

Screening programmes for Hepatitis B/C in Europe

Towards universal access

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Integration of collaborative TB/HIV activities with harm reduction services

HIV PrEP: Women? Why? How?

Emerging epidemics: Will they derail progress? Eastern/Central Europe

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Formative Research results

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

Screening for Cervical Cancer in Europe

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

EU Health Programme: working together to improve public health in Europe

HIV in Ireland 2016 Report

COMMISSION OF THE EUROPEAN COMMUNITIES

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion

Maltese Presidency of the Council of the European Union. Ministry for Health

City Profiles Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men

STI and HIV Prevention and Care among Sex Workers

HIV/AIDS MODULE. Rationale

Towards Integrated Syndromic Surveillance in Europe?

Dr Alison Brown. Public Health England. 15 th Annual Conference of the National HIV Nurses Association (NHIVNA)

EuroHIV: HIV/AIDS surveillance in Europe

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

Annual Epidemiological Report

Extrapolation and potential impact of IPHS deployment in Europe

PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe?

Sialon : bio-behavioural study among MSM in Brussels and other European cities

INTRAVENOUS INJECTING DRUG USE.

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Alcohol Prevention Day

Transcription:

ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg, 10-11 December 2013

Outline Background What we know about HIV among migrant populations in the EU/EEA Surveillance data Dublin data Sexual transmission of HIV among migrant populations Conclusions/Next steps

Background

Migrant Health Report Series 2009-2011

Raising the profile of migrant health and HIV ECDC/CDC/PHAC/IOM joint collaboration UN High-Level Meeting on AIDS 2011 World AIDS Conference Washington 2012

Background and objective Background Many countries identify migrants as a key population in their response to HIV, but very few have data to monitor their response In 2012, several countries approached ECDC stating their plans to conduct national surveys in relation to migrant health and HIV asking if ECDC could: - Share good examples of national surveys on HIV among migrants - Recommend a set of indicators to include in national surveys Objectives: Highlight what we know in terms of HIV among migrant populations Facilitate the exchange of national experiences in monitoring HIV among migrant populations Get expert input and advise on how best to move forward the issue of monitoring HIV among migrant populations

What do we know about HIV among migrants in the EU?

HIV infections reported EU/EEA, 2006-2012 Transmission mode and origin, adjusted for reporting delay 10000 9000 Men who have sex with men 8000 7000 Heterosexual cases, excluding cases from Sub-Saharan African countries Number of cases 6000 5000 4000 3000-52% Other/undetermined Heterosexual cases from sub- Saharan African countries 2000 Injecting drug users 1000 0 2006 2007 2008 2009 2010 2011 2012 Mother-to-child transmission Year of diagnosis Predominant mode of transmission : men who have sex with men Data were not included or not available from Estonia, Poland, Spain, Italy. Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012

Strong evidence that migrants are particularly affected by HIV in EU/EEA countries 36% of all diagnosed HIV cases in 2011 were among migrants 80 70 Percent 60 50 40 EU/EEA 36% 30 20 10 0 Migrant health: Sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions ECDC (2013)

Dublin Declaration thematic report on migrants

International indicators related to most at risk populations Indicator PWID MSM Sex workers Programme coverage X X X Condom use X X X Testing X X X Behaviour X X X Prevalence X X X NCPI Policy questions X X X

International indicators related to most at risk populations, including migrants Indicator PWID MSM Sex workers Migrants Programme coverage X X X X Prevalence X X X X Condom use X X X X Testing X X X X NCPI Policy questions X X X X Late diagnosis X X X X

76% of countries identify migrants as an important sub-population in their HIV response ECDC. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; 2013. Yes No No data reported Non EU/EEA

Few countries report data on HIV prevalence among migrants ECDC. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; 2013.

Even fewer countries report data on HIV testing or condom use among migrants

Availability of ART in key populations ECDC. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; 2013. Percentage of responding countries reporting that ART is available for specific key-populations 100% Government Civil Society 80% 60% 40% 20% 0% People who inject drugs Men who have sex with men Migrants (generally) Undocumented migrants (specifically) Prisoners

Availability of ART for undocumented migrants 2012 ECDC. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm: ECDC; 2013.

Late diagnosis

CD4 count at time of diagnosis EU/EEA, 2012

Late diagnosis is a critical issue in EU/EEA Of those with a CD4 count at time of diagnosis, half (49%) are diagnosed late As a result, there are a large number of people that need ART but are not receiving it Late diagnosis leads to increased morbidity and mortality People diagnosed early are more likely to respond well to treatment Early diagnosis and treatment reduces the likelihood of onward transmission

Late HIV diagnosis by transmission mode EU/EEA, 2012 70 60 50 61% % <350 % <200 55% 40 30 38% 34% 38% 20 20% 10 0 Heterosexual cases from Sub-Saharan Africa IDU MSM

Sexual transmission of HIV among migrant populations

Sexual transmission of HIV within migrant groups and implications for effective interventions (Aug 2013) Project inspired by Burns et al (2009) showing that the proportion of migrants infected by HIV in London was higher than had previously been thought Developing and delivering targeted primary prevention programmes There is evidence to show that some on-going post-migration HIV acquisition is occurring in EU countries However, it is difficult to quantify the degree to which this is occurring Member States should consider applying an objective method for assigning probable country of infection

Estimating UK HIV acquisition clinic report-based method Black Africans born abroad and diagnosed with HIV 2004-2010 Clinic-based estimate 46% 24% 18% 7% Source: Rice BD, Elford J, Yin Z et al (2012). A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV in the UK. AIDS 26 (15): 1961-6

Estimating UK HIV acquisition CD4-based method Black Africans born abroad and diagnosed with HIV 2004-2010 Clinic-based estimate CD4-based estimate 44% 25% 18% 7% Source: Rice BD, Elford J, Yin Z et al (2012). A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV in the UK. AIDS 26 (15): 1961-6

Applying an objective method for assigning probable country of HIV infection in 4 countries ECDC launched a project with Public Health England: Necessary variables needed to apply the UK-method of assigning probable country of HIV infection Country of birth Date of arrival CD4 count at time of diagnosis 13 countries have the necessary variables Pilot the UK-method for assigning probable country of infection in some countries that have the necessary variables 1 (Sweden, Belgium, Italy and Portugal ) The outcomes of this pilot will be presented and discussed at the HIV network meeting in Stockholm May 2014 1 Belgium, Denmark, France, Greece, Italy, Lithuania, Luxembourg, Malta, Portugal, Romania, Slovakia, Sweden and the UK

Conclusions and next steps

Ways to improve the monitoring of HIV among migrant populations - Conclusions/Next steps 1. Make better use of existing data (i) ECDC to use data presented at the workshop in the Dublin 2014 report (ii) Put together a journal supplement to coincide with the AIDS Conference 2014 (iii) Organise a workshop at the EUPHA Migrant Health Conference (Granada, April 2014) 2. Improve probable country of infection estimates ECDC, together with PHE, will organise a workshop to pilot the UK-method (CD4) with 4 countries (SE, BE, IT, PT) 3. ECDC to establish an informal network for countries to share national experiences on the subject of monitoring HIV among migrants 4. ECDC to develop a paper on the public health benefits for providing ART to irregular migrants

Conclusions/Next steps 5. Migrant MSM are particularly at risk for HIV acquisition after migration to the EU i. ECDC to explore feasibility of an in-depth study to further analyse EMIS data in relation to HIV among migrant MSM across the European region 6. Member states also expressed a need to initiate an EMIS-like study, but focused on migrants at higher risk for HIV and other infectious diseases (i.e. TB, hepatitis B and C)

Meeting report available upon request

Thank You